Electrolyte and Acid-Base Disorders in Chronic Kidney Disease and End-Stage Kidney Failure

被引:125
作者
Dhondup, Tsering [1 ]
Qian, Qi [1 ]
机构
[1] Mayo Clin, Coll Med, Dept Med, Div Nephrol & Hypertens, 200 First St SW, Rochester, MN 55905 USA
关键词
Dyskalemia; Acidosis; Mineral bone disorder; Dysnatremia; Dysmagnesemia; Chronic kidney disease; End-stage renal disease; ORAL SODIUM-BICARBONATE; FIBROBLAST GROWTH FACTOR-23; CALCIUM ACETATE/MAGNESIUM CARBONATE; VITAMIN-D; PARATHYROID-HORMONE; METABOLIC-ACIDOSIS; SERUM BICARBONATE; HEMODIALYSIS-PATIENTS; MINERAL METABOLISM; MORTALITY RISK;
D O I
10.1159/000452725
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The kidneys play a pivotal role in the regulation of electrolyte and acid-base balance. With progressive loss of kidney function, derangements in electrolytes and acid-base inevitably occur and contribute to poor patient outcomes. As chronic kidney disease (CKD) has become a worldwide epidemic, medical providers are increasingly confronted with such problems. Adequate diagnosis and treatment will minimize complications and can potentially be lifesaving. In this review, we discuss the current understanding of the disease process, clinical presentation, diagnosis and treatment strategies, integrating up-to-date knowledge in the field. Although electrolyte and acid-base derangements are significant causes of morbidity and mortality in CKD and end-stage renal disease patients, they can be effectively managed through a timely institution of combined preventive measures and pharmacological therapy. Exciting advances and several upcoming outcome trials will provide further information to guide treatment and improve patient outcomes. (C) 2017 S. Karger AG, Basel
引用
收藏
页码:179 / 188
页数:10
相关论文
共 132 条
[1]   Effects of Oral Sodium Bicarbonate in Patients with CKD [J].
Abramowitz, Matthew K. ;
Melamed, Michal L. ;
Bauer, Carolyn ;
Raff, Amanda C. ;
Hostetter, Thomas H. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (05) :714-720
[2]   Primary care -: Hypernatremia [J].
Adrogué, HJ ;
Madias, NE .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (20) :1493-1499
[3]   Mechanisms of disease:: Sodium and potassium in the pathogenesis of hypertension [J].
Adrogue, Horacio J. ;
Madias, Nicolaos E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (19) :1966-1978
[4]   FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1/2-SGK1 signaling pathway [J].
Andrukhova, Olena ;
Zeitz, Ute ;
Goetz, Regina ;
Mohammadi, Moosa ;
Lanske, Beate ;
Erben, Reinhold G. .
BONE, 2012, 51 (03) :621-628
[5]  
[Anonymous], 2013, Kidney Int Suppl, DOI [10.1038/kisup.2012.73, DOI 10.1038/KISUP.2012.73]
[6]   Induction of the vitamin D 24-hydroxylase (CYP24) by 1,25-dihydroxyvitamin D3 is regulated by parathyroid hormone in UMR106 osteoblastic cells [J].
Armbrecht, HJ ;
Hodam, TL ;
Boltz, MA ;
Partridge, NC ;
Brown, AJ ;
Kumar, VB .
ENDOCRINOLOGY, 1998, 139 (08) :3375-3381
[7]   Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease The AMETHYST-DN Randomized Clinical Trial [J].
Bakris, George L. ;
Pitt, Bertram ;
Weir, Matthew R. ;
Freeman, Mason W. ;
Mayo, Martha R. ;
Garza, Dahlia ;
Stasiv, Yuri ;
Zawadzki, Rezi ;
Berman, Lance ;
Bushinsky, David A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (02) :151-161
[8]   The effect of hyperkalaemia on cardiac rhythm devices [J].
Barold, S. Serge ;
Herweg, Bengt .
EUROPACE, 2014, 16 (04) :467-476
[9]  
Berl T, 2008, J AM SOC NEPHROL, V19, P1076, DOI 10.1681/ASN.2007091042
[10]  
Blagodatski Artem, 2014, Mol Cell Ther, V2, P28